JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥60 | ¥105 | ¥176 | ¥279 |
| - Cash | ¥13 | ¥19 | ¥13 | ¥31 |
| + Debt | ¥38 | ¥23 | ¥23 | ¥18 |
| Enterprise Value | ¥85 | ¥109 | ¥185 | ¥267 |
| Revenue | ¥33 | ¥43 | ¥34 | ¥51 |
| % Growth | -22.9% | 24.8% | -32.8% | – |
| Gross Profit | ¥22 | ¥31 | ¥25 | ¥41 |
| % Margin | 65.2% | 72.9% | 74.1% | 79.5% |
| EBITDA | -¥3 | ¥11 | ¥7 | ¥21 |
| % Margin | -8.7% | 24.6% | 21.7% | 41.9% |
| Net Income | -¥5 | ¥6 | ¥4 | ¥15 |
| % Margin | -14.4% | 12.8% | 11% | 28.4% |
| EPS Diluted | -38.43 | 43.92 | 30.22 | 116.79 |
| % Growth | -187.5% | 45.3% | -74.1% | – |
| Operating Cash Flow | -¥5 | ¥9 | -¥6 | ¥9 |
| Capital Expenditures | -¥10 | -¥2 | -¥9 | -¥11 |
| Free Cash Flow | -¥15 | ¥7 | -¥14 | -¥2 |